Lilly Confirms Date and Conference Call for Second-Quarter 2024 Financial Results Announcement
Eli Lilly and Company (NYSE: LLY) has announced that it will release its second-quarter 2024 financial results on August 8, 2024. The company will host a conference call at 10 a.m. Eastern time on the same day to discuss the financial performance with investors, media, and the general public.
A live webcast of the conference call will be accessible through a link on Lilly's investor relations website. For those unable to attend the live event, a replay will be made available on the same website following the call.
Eli Lilly and Company (NYSE: LLY) ha annunciato che rilascerà i suoi risultati finanziari per il secondo trimestre del 2024 il 8 agosto 2024. L'azienda organizzerà una conferenza telefonica alle 10:00 ora orientale dello stesso giorno per discutere le performance finanziarie con investitori, media e il pubblico generale.
Una diretta web della conferenza sarà accessibile tramite un collegamento sul sito delle relazioni con gli investitori di Lilly. Per coloro che non possono partecipare all'evento dal vivo, una registrazione sarà disponibile sullo stesso sito dopo la chiamata.
Eli Lilly and Company (NYSE: LLY) ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el 8 de agosto de 2024. La compañía llevará a cabo una conferencia telefónica a las 10 a.m. hora del Este el mismo día para discutir el rendimiento financiero con inversores, medios de comunicación y el público en general.
Una transmisión en vivo de la conferencia estará disponible a través de un enlace en el sitio web de relaciones con los inversores de Lilly. Para aquellos que no puedan asistir al evento en vivo, se ofrecerá una retransmisión en el mismo sitio después de la llamada.
엘리 릴리 및 회사(NYSE: LLY)는 2024년 2분기 재무 결과를 2024년 8월 8일에 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 오전 10시에 투자자, 언론 및 일반 대중과 재무 성과에 대해 논의하기 위해 컨퍼런스 콜을 개최할 것입니다.
이번 컨퍼런스 콜의 생중계는 릴리의 투자자 관계 웹사이트의 링크를 통해 접근할 수 있습니다. 실시간 이벤트에 참석할 수 없는 분들을 위해, 콜 후 동일한 웹사이트에서 재생이 제공될 예정입니다.
Eli Lilly and Company (NYSE: LLY) a annoncé qu'il publiera ses résultats financiers du deuxième trimestre 2024 le 8 août 2024. L'entreprise organisera une conférence téléphonique à 10h00, heure de l'Est le même jour pour discuter des performances financières avec les investisseurs, les médias et le grand public.
Un webinaire en direct de la conférence sera accessible via un lien sur le site Web des relations avec les investisseurs de Lilly. Pour ceux qui ne peuvent pas assister à l'événement en direct, une rediffusion sera mise à disposition sur le même site après l'appel.
Eli Lilly and Company (NYSE: LLY) hat angekündigt, dass es seine Finanzergebnisse für das zweite Quartal 2024 am 8. August 2024 veröffentlichen wird. Das Unternehmen veranstaltet am selben Tag um 10 Uhr Eastern Time eine Telefonkonferenz, um die finanzielle Leistung mit Investoren, Medien und der Öffentlichkeit zu diskutieren.
Ein Live-Stream der Telefonkonferenz wird über einen Link auf der Investor-Relations-Website von Lilly zugänglich sein. Für diejenigen, die an der Live-Veranstaltung nicht teilnehmen können, wird eine Wiederholung auf derselben Website nach dem Anruf verfügbar sein.
- None.
- None.
The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news or follow us on Facebook, Instagram and LinkedIn. F-LLY
Refer to: | Jordan Bishop; jordan.bishop@lilly.com; 317-374-1878 (Media) |
Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-second-quarter-2024-financial-results-announcement-302205880.html
SOURCE Eli Lilly and Company
FAQ
When will Eli Lilly (LLY) release its Q2 2024 financial results?
What time is Eli Lilly's (LLY) Q2 2024 earnings conference call?
How can I access Eli Lilly's (LLY) Q2 2024 earnings call?
Will there be a replay available for Eli Lilly's (LLY) Q2 2024 earnings call?
